Proofdx

1 known investors

Proof Diagnostics developed genome engineering tools and a portable diagnostic system for detecting infectious diseases using CRISPR-based technologies, along with a library of OMEGA non-Cas enzymes for both therapeutic and diagnostic applications. The company was acquired by Ginkgo Bioworks in 2024.